SCHEMBL1685016

SCHEMBL1685016

O=c1occcc1O.[Fe]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12501791 1.00 KDM4E (0.46)
SCHEMBL28143225 0.97 KDM4E (0.48)
SCHEMBL28318997 0.97
SCHEMBL284309 0.97
Water SCHEMBL27495950 0.95
SCHEMBL10657468 0.95
SCHEMBL4287794 0.95
Phosphine SCHEMBL28140868 0.95
SCHEMBL9812780 0.95
Methyl Alcohol SCHEMBL27778739 0.93 KDM4E (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3192793-B1 COMPOSITIONS CONTAINING IRON HYDROXYPYRONE SHIELD TX UK LTD (GB) 2022-03-16 EP claimed
EP-3116548-B1 COMPOSITION SHIELD TX UK LTD (GB) 2021-02-17 EP claimed
EP-2668175-B2 PROCESS FOR PREPARING AN IRON HYDROXYPYRONE SHIELD TX UK LTD (GB) 2021-01-06 EP claimed
EP-3192793-A1 COMPOSITIONS CONTAINING IRON HYDROXYPYRONE Shield TX (UK) Limited (GB) 2017-07-19 EP claimed
US-20170165274-A1 COMPOSITION SHIELD TX (UK) LTD. (GB) 2017-06-15 US claimed
EP-2668175-B1 PROCESS FOR PREPARING AN IRON HYDROXYPYRONE SHIELD TX (UK) LTD (GB) 2017-03-08 EP claimed
EP-3116548-A1 COMPOSITION Shield TX (UK) Limited (GB) 2017-01-18 EP claimed
CN-106102718-A Compositions 英国神盾TX股份有限公司 2016-11-09 CN claimed
US-20160120902-A1 MONO (IRON HYDROXYPYRONE) AND COMBINATION (IRON HYDROXYPYRONE AND GI INFLAMMATION INHIBITING AGENTS) COMPOSITIONS FOR ANAEMIA OR H. PYLORI INFECTIONS IRON THERAPEUTICS HOLDINGS AG (CH) 2016-05-05 US claimed
US-9248148-B2 Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and GI inflammation inhibiting agents) compositions for anaemia or H. pylori infections IRON THERAPEUTICS HOLDINGS AG (CH) 2016-02-02 US claimed
WO-2012101442-A1 PROCESS IRON THERAPEUTICS HOLDINGS AG (CH) 2012-08-02 WO claimed
US-20110177172-A1 MONO (IRON HYDROXYPYRONE) AND COMBINATION (IRON HYDROXYPYRONE AND GI INFLAMMATION INHIBITING AGENTS) COMPOSITIONS FOR ANAEMIA OR H. PYLORI INFECTIONS VITRA PHARMACEUTICALS LIMITED (GB) 2011-07-21 US claimed
EP-2303289-A1 MONO ( IRON HYDROXYPYRONE ) AND COMBINATION ( IRON HYDROXYPYRONE AND GI INFLAMMATION INHIBITING AGENTS ) COMPOSITIONS FOR ANAEMIA OR H. PYLORI INFECTIONS Iron Therapeutics Holdings AG (CH) 2011-04-06 EP claimed
WO-2009138761-A1 MONO ( IRON HYDROXYPYRONE ) AND COMBINATION ( IRON HYDROXYPYRONE AND GI INFLAMMATION INHIBITING AGENTS ) COMPOSITIONS FOR ANAEMIA OR H. PYLORI INFECTIONS VITRA PHARMACEUTICALS LIMITED (GB) 2009-11-19 WO claimed
US-7459569-B2 Method of forming iron hydroxypyrone compounds VITRA PHARMACEUTICALS LIMITED (GB) 2008-12-02 US claimed
CN-101102762-A Compositions including iron DRUGTECH CORP (US) 2008-01-09 CN claimed
EP-1506183-B1 METHOD OF FORMING IRON HYDROXYPYRONE COMPOUNDS VITRA PHARMACEUTICALS LTD (GB) 2007-01-24 EP claimed
US-20050250754-A1 Method of forming iron hydroxypyrone compounds Shield TX (UK) Limited (GB) 2005-11-10 US claimed
EP-1506183-A1 METHOD OF FORMING IRON HYDROXYPYRONE COMPOUNDS Vitra Pharmaceuticals Ltd. (GB) 2005-02-16 EP claimed
WO-2003097627-A1 METHOD OF FORMING IRON HYDROXYPYRONE COMPOUNDS VITRA PHARMACEUTICALS LIMITED (GB) 2003-11-27 WO claimed